Source:http://linkedlifedata.com/resource/pubmed/id/12824095
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
12
|
| pubmed:dateCreated |
2003-6-25
|
| pubmed:abstractText |
The Thrombosis Prevention Trial was a primary prevention factorial trial that reported a reduction in the risk of coronary heart disease (CHD) with warfarin and/or aspirin. This article examines compliance (duration of treatment) with warfarin treatment and whether warfarin has a retained effect.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jun
|
| pubmed:issn |
0003-9926
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
23
|
| pubmed:volume |
163
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1454-60
|
| pubmed:dateRevised |
2007-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:12824095-Anticoagulants,
pubmed-meshheading:12824095-Aspirin,
pubmed-meshheading:12824095-Coronary Disease,
pubmed-meshheading:12824095-Double-Blind Method,
pubmed-meshheading:12824095-Follow-Up Studies,
pubmed-meshheading:12824095-Humans,
pubmed-meshheading:12824095-Male,
pubmed-meshheading:12824095-Middle Aged,
pubmed-meshheading:12824095-Patient Compliance,
pubmed-meshheading:12824095-Platelet Aggregation Inhibitors,
pubmed-meshheading:12824095-Stroke,
pubmed-meshheading:12824095-Thrombosis,
pubmed-meshheading:12824095-Warfarin
|
| pubmed:year |
2003
|
| pubmed:articleTitle |
Thrombosis prevention trial: compliance with warfarin treatment and investigation of a retained effect.
|
| pubmed:affiliation |
Department of Environmental and Preventive Medicine, Medical Research Council Epidemiology and Medical Care Unit, Wolfson Institute of Preventive Medicine, London, England. a.r.rudnicka@qmul.ac.uk
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|